Radiation Oncology Journal

Changes in clinical guidelines for the treatment of colorectal cancer in 2024

S. S. Gordeev, M. Yu. Fedyanin, M. V. Chernykh, Ye. G. Rubakov, A. M. Karachun, A. A. Nevolskikh, A. A. Tryakin, Z. Z. Mamedli

MRI-based Multiregional Radiomics for Pretreatment Prediction of Distant Metastasis After Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer

Rui Zhao, Lijuan Wan, Shuang Chen, Wenjing Peng, Xiangchun Liu, Sicong Wang, Lin Li, Hongmei Zhang

Clinical significance of the maximum standardized uptake value on positron emission tomography to predict treatment response and outcomes in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy

Takao Tsuneki, Takeru Matsuda, Ryuichiro Sawada, Hiroshi Hasegawa, Kimihiro Yamashita, Yasufumi Koterazawa, Hitoshi Harada, Naoki Urakawa, Hironobu Goto, Shingo Kanaji, Yoshihiro Kakeji

Clinical Analysis of the Efficacy and Safety of Different Neoadjuvant Strategies in the Treatment of Locally Advanced Rectal Cancer

Wanghua Chen, Wenling Wang, Sicheng Huang, Lili Zhou, Gang Wang, Weiwei Chen

The pattern of bowel dysfunction in patients with rectal cancer following the multimodal treatment: anorectal manometric measurements at before and after chemoradiation therapy, and postoperative 1 year

Ri Na Yoo, Bong-Hyeon Kye, HyungJin Kim, Gun Kim, Hyeon-Min Cho

Annals of Coloproctology.2023; 39(1): 32. CrossRef

Dynamic radiomics for predicting the efficacy of antiangiogenic therapy in colorectal liver metastases

Hui Qu, Huan Zhai, Shuairan Zhang, Wenjuan Chen, Hongshan Zhong, Xiaoyu Cui

Total neoadjuvant treatment to increase the clinical complete response rate for distal locally advanced rectal cancer (TESS): A study protocol of a prospective, open‐label, multicenter, single‐arm, phase 2 trial

Shuang Liu, XiaoZhong Wang, YeZhong Zhuang, ShouMin Bai, XiaoJun Wu, YiJing Ye, HuiLong Luo, HaiNa Yu, QiaoXuan Wang, Hui Chang, ZhiFan Zeng, PeiQiang Cai, ZhiZhong Pan, YuanHong Gao, Gong Chen, WeiWei Xiao

Applying a neoscore in locally advanced rectal cancer is beneficial in predicting local recurrences after surgery

One-Week versus Two-Week Chemoradiotherapy Followed by Curative Surgery in Rectal Cancer: Long-Term Comparative Pooled Analysis of Two Prospective Multicenter Phase II Trials

Soo-Yoon Sung, Dae Yong Kim, Hong Seok Jang, Tae Hyun Kim, Hee Chul Park, Eui Kyu Chie, Taek-Keun Nam, Sung Hwan Kim, Jong Hoon Lee

Cancer Research and Treatment.2023; 55(3): 918. CrossRef

Implication of MRI Risk Stratification System on the Survival Benefits of Adjuvant Chemotherapy After Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer

Rui Zhao, Wei Zhao, Yumeng Zhu, Lijuan Wan, Shuang Chen, Qing Zhao, Xinming Zhao, Hongmei Zhang

Investigating anorectal function using postoperative MRI-based fibrosis score in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy: a two-center study

Yuan Yuan, Yue Yu, Yi Qun Sun, Shuai Li, Hai Di Lu, Xiao Lu Ma, Jian Ping Lu, Cheng Wei Shao, Wei Zhang, Tong Tong, Xian Hua Gao, Fu Shen

Oxaliplatin-based adjuvant chemotherapy rather than fluorouracil-based chemotherapy in rectal cancer is more efficient to decrease distant metastasis and increase survival after preoperative chemoradiotherapy and surgery: a meta-analysis

Jin Ho Song, Jong Hoon Lee, Sung Hwan Kim, Jun Won Um

International Journal of Colorectal Disease.2022; 37(3): 649. CrossRef

Postoperative hypofractionated–accelerated radiotherapy (HypoAR) for locally advanced rectal cancer

Michael I Koukourakis, Christos Kavazis, Axiotis Giagtzidis, Panagiotis Mamalis, Alexandra Tsaroucha, Sotirios Botaitis, Alexandra Giatromanolaki, Michael Pitiakoudis

Japanese Journal of Clinical Oncology.2022; 52(5): 493. CrossRef

Filip Pazdírek, Michal Vjaclovský, Marek Grega, Jiří Hoch

Pretreatment blood biomarkers combined with magnetic resonance imaging predict responses to neoadjuvant chemoradiotherapy in locally advanced rectal cancer

Xinyu Shi, Min Zhao, Bo Shi, Guoliang Chen, Huihui Yao, Junjie Chen, Daiwei Wan, Wen Gu, Songbing He

Pathologic Implications of Radial Resection Margin and Perineural Invasion to Adjuvant Chemotherapy after Preoperative Chemoradiotherapy and Surgery for Rectal Cancer: A Multi-Institutional and Case-Matched Control Study

Soo-Yoon Sung, Sung Hwan Kim, Hong Seok Jang, Jin Ho Song, Songmi Jeong, Ji-Han Jung, Jong Hoon Lee

Correlation between T stage and lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy

Seijong Kim, Jung Wook Huh, Woo Yong Lee, Seong Hyeon Yun, Hee Cheol Kim, Yong Beom Cho, Yoonah Park, Jung Kyong Shin

Therapeutic Advances in Medical Oncology.2022; 14: 175883592211326. CrossRef

MRI-defined high-risk rectal cancer patients: outcome comparison between neoadjuvant chemoradiotherapy plus TME and TME plus adjuvant chemotherapy or TME alone

Xiaoxuan Jia, Peiyi Xie, Liang Bi, Xiaochun Meng, Ziqiang Wang, Nan Hong, Yi Wang

The British Journal of Radiology.2021;[Epub] CrossRef

Magnetic resonance imaging-radiomics evaluation of response to chemotherapy for synchronous liver metastasis of colorectal cancer

Yan-Qing Ma, Yang Wen, Hong Liang, Jian-Guo Zhong, Pei-Pei Pang

World Journal of Gastroenterology.2021; 27(38): 6465. CrossRef

Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline

Jennifer Y. Wo, Christopher J. Anker, Jonathan B. Ashman, Nishin A. Bhadkamkar, Lisa Bradfield, Daniel T. Chang, Jennifer Dorth, Julio Garcia-Aguilar, David Goff, Dustin Jacqmin, Patrick Kelly, Neil B. Newman, Jeffrey Olsen, Ann C. Raldow, Erika Ruiz-Garc

Practical Radiation Oncology.2021; 11(1): 13. CrossRef

Short-term outcomes of laparoscopic intersphincteric resection with intraoperative radiotherapy using low-energy X-rays for primary locally advanced low rectal cancer: a single center experience

Wangsheng Xue, Shuang Wang, Zeyun Zhao, Yongbo Li, An Shang, Donglin Li, Jianzheng Yang, Tiejun Wang, Min Wang

World Journal of Surgical Oncology.2020;[Epub] CrossRef

Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer

Gyu Sang Yoo, Hee Chul Park, Jeong Il Yu, Doo Ho Choi, Won Kyung Cho, Young Suk Park, Joon Oh Park, Ho Yeong Lim, Won Ki Kang, Woo Yong Lee, Hee Cheol Kim, Seong Hyeon Yun, Yong Beom Cho, Yoon Ah Park, Kyoung Doo Song, Seok-Hyung Kim, Sang Yun Ha

Cancer Research and Treatment.2020; 52(2): 446. CrossRef

Gastrointestinal Cancers: Moving the Needle for Rectal, Gastroesophageal, Pancreaticobiliary, and Liver Cancers

Jordan Kharofa, Christopher L. Hallemeier, Florence Huguet, Christopher J. Anker, Michael H. Buckstein, Diana Tait, Jeffrey R. Olsen, Salma K. Jabbour

International Journal of Radiation Oncology*Biology*Physics.2020; 106(4): 653. CrossRef

Neoadjuvant radiotherapy improves overall survival for T3/4N+M0 rectal cancer patients: a population-based study of 20300 patients

Feng Zhao, Jili Wang, Hao Yu, Xiaofei Cheng, Xinke Li, Xuan Zhu, Xiangming Xu, Jianjiang Lin, Xin Chen, Senxiang Yan

Dose–time fractionation schedules of preoperative radiotherapy and timing to surgery for rectal cancer

Fu Jin, Huanli Luo, Juan Zhou, Yongzhong Wu, Hao Sun, Hongliang Liu, Xiaodong Zheng, Ying Wang

Therapeutic Advances in Medical Oncology.2020; 12: 175883592090753. CrossRef

Current Options in the Management of Colorectal Cancer in Developing Countries: Central America Experience

Anny Ochoa-Hernandez, Karen Giron, Jennie Meier, Ana Paulina Charchalac

Current Colorectal Cancer Reports.2020; 16(3): 49. CrossRef

Total Neoadjuvant Therapy for Rectal Cancer: Current Status and Future Directions

Current Colorectal Cancer Reports.2020; 16(6): 125. CrossRef

Nadir/pre-chemoradiotherapy ratio of white blood-cell count can predict tumor response and recurrence-free survival in locally advanced rectal cancer: a multi-institutional analysis

Joo Hwan Lee, Jae Uk Jeong, Sung Hwan Kim, Taek Keun Nam, Jong Hoon Lee, Songmi Jeong, Mina Yu, Hong Seok Jang

International Journal of Colorectal Disease.2019; 34(1): 105. CrossRef

Pathologic Staging Inconsistency Between ypT4N0 (stage II) and ypT1-2N1 (stage III) After Preoperative Chemoradiotherapy and Total Mesorectal Excision in Rectal Cancer: A Multi-Institutional Study

Joo Hwan Lee, Mina Yu, Sung Hwan Kim, Jong Hoon Lee, Soo-Yoon Sung, Bae Kwon Jeong, Songmi Jeong, Taek Keun Nam, Jae Uk Jeong, Hong Seok Jang

Clinical Colorectal Cancer.2019; 18(1): e130. CrossRef

Adjuvant Chemotherapy in Rectal Cancer Patients Treated With Preoperative Chemoradiation and Total Mesorectal Excision: A Multicenter and Retrospective Propensity-Score Matching Study

Mi Joo Chung, Joo Hwan Lee, Jong Hoon Lee, Sung Hwan Kim, Jin Ho Song, Songmi Jeong, Mina Yu, Taek Keun Nam, Jae Uk Jeong, Hong Seok Jang

International Journal of Radiation Oncology*Biology*Physics.2019; 103(2): 438. CrossRef

Significance of perineural and lymphovascular invasion in locally advanced rectal cancer treated by preoperative chemoradiotherapy and radical surgery: Can perineural invasion be an indication of adjuvant chemotherapy?

Jin Ho Song, Mina Yu, Ki Mun Kang, Jong Hoon Lee, Sung Hwan Kim, Taek Keun Nam, Jae Uk Jeong, Hong Seok Jang, Jeong Won Lee, Ji-Han Jung

Radiotherapy and Oncology.2019; 133: 125. CrossRef

MRI for Restaging Locally Advanced Rectal Cancer: Detailed Analysis of Discrepancies With the Pathologic Reference Standard

Xiaoxuan Jia, Yinli Zhang, Yi Wang, Caizhen Feng, Danhua Shen, Yingjiang Ye, Nan Hong

American Journal of Roentgenology.2019; 213(5): 1081. CrossRef

Oncologic Risk of Rectal Preservation Against Medical Advice After Chemoradiotherapy for Rectal Cancer: A Multicenter Comparative Cross‐Sectional Study with Rectal Preservation as Supported by Surgeon

Kwang‐Seop Song, Sung Chan Park, Dae Kyung Sohn, Jae Hwan Oh, Min Jung Kim, Ji Won Park, Seung‐Bum Ryoo, Seung‐Yong Jeong, Kyu Joo Park, Heung‐Kwon Oh, Duck‐Woo Kim, Sung‐Bum Kang

World Journal of Surgery.2019; 43(12): 3216. CrossRef

The role of chemotherapy in localized and locally advanced rectal cancer: A systematic revision

Susana Roselló, Federica Papaccio, Desamparados Roda, Noelia Tarazona, Andrés Cervantes

Current Trends in the Rate of Rectal Cancer Restorative Operations in the Era of Neoadjuvant Chemoradiation

Holly B. Cunningham, Joshua J. Weis, Luis R. Taveras

Current Colorectal Cancer Reports.2018; 14(1): 31. CrossRef

Advances in Radiotherapy for Locally Advanced Rectal Cancer

Advances in Clinical Medicine.2018; 08(01): 59. CrossRef

Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy in rectal cancer treated with neoadjuvant concurrent chemoradiation: a meta-analysis and pooled-analysis of acute toxicity

Chan Woo Wee, Hyun-Cheol Kang, Hong-Gyun Wu, Eui Kyu Chie, Noorie Choi, Jong Min Park, Jung-in Kim, Chun-Ming Huang, Jaw-Yuan Wang, Shu Y Ng, Karyn A Goodman

Japanese Journal of Clinical Oncology.2018; 48(5): 458. CrossRef

Comparative survival analysis of preoperative and postoperative radiotherapy in stage II-III rectal cancer on the basis of long-term population data

Total mesorectal excision with or without preoperative chemoradiotherapy for resectable mid/low rectal cancer: a long‐term analysis of a prospective, single‐center, randomized trial

Fulong Wang, Wenhua Fan, Jianhong Peng, Zhenhai Lu, Zhizhong Pan, Liren Li, Yuanhong Gao, Hui Li, Gong Chen, Xiaojun Wu, Peirong Ding, Zhifan Zeng, Desen Wan